| SKU | ISG000159 |
| Brand | Amaryl |
| Categories | Medication & Treatments |
| Color | black |
| Concentrations | 2 Mg |
| Shop by Concerns | Diabetes Complications Prevention |
| Gender | Unisex |
| Shop By Goals | Blood Thinning |
| Imported Or Local | Local |
| Ingredient | Glimepiride |
| UPC | 6223003990077 |
| Product Form | Tablets |
| Specialty | Clinically Tested Prescription only |
| Sub Categories | Insulin And Diabetic Medicines |
| Unit Count | 30 Tablets |
| Warning | allergy risk for fish or seafood Not for Type 1 Diabetes or Ketoacidosis Use under medical supervision only Risk of hypoglycemia |
Amaryl 2 Mg 30 Tablets
Description:
Amaryl 2 mg 30 tablets is an oral prescription antidiabetic medicine containing glimepiride, a sulfonylurea used for the management of type 2 diabetes mellitus in adults. It helps control high blood sugar by stimulating the pancreas to release more insulin and improving the body’s use of insulin. Amaryl is typically used as part of a comprehensive diabetes care plan that includes diet, exercise, and regular blood glucose monitoring, and may be used alone or in combination with other antidiabetic medications such as metformin or insulin.
Indications:
- Management of type 2 diabetes mellitus in adults when blood glucose levels are not adequately controlled by diet, physical activity, and weight reduction alone.
- May be used as monotherapy or in combination with other oral antidiabetic agents (e.g., metformin) or insulin as prescribed by a physician.
- Helps reduce symptoms and complications associated with chronic hyperglycemia such as excessive thirst, frequent urination, fatigue, and risk of long-term microvascular and macrovascular complications.
Active Ingredients / Key Components:
- Glimepiride – 2 mg per tablet.
- Excipients: Information on inactive ingredients (e.g., fillers, binders, coloring agents) is not available in the provided data; please refer to the official package leaflet for the full excipient list.
Dosage & Administration / How to Use:
- The dose must always be individualized by the treating physician based on blood glucose response and patient profile.
- Recommended starting dose: usually 1–2 mg once daily, taken with breakfast or the first main meal of the day.
- Usual maintenance dose: adjusted gradually according to blood glucose measurements. Dose titration is typically done in steps (e.g., 1 mg increments) at intervals of several days to weeks, as advised by the physician.
- Maximum recommended dose: information provided states a maximum of 2 mg/day; however, standard references often allow higher doses. Follow your doctor’s specific prescription and do not exceed the prescribed dose.
- Tablets should be swallowed whole with a sufficient amount of water; do not crush or chew unless advised by a healthcare professional.
- Take at the same time each day to maintain stable blood sugar control.
- If you miss a dose, take it as soon as you remember on the same day. If it is almost time for your next dose, skip the missed dose. Do not double the dose to make up for a missed one.
- Use in elderly patients or those with renal or hepatic impairment requires careful dose adjustment and close medical supervision.
Clinical Benefits:
- Helps lower and control elevated blood glucose levels in adults with type 2 diabetes mellitus.
- Stimulates insulin secretion from functioning pancreatic beta cells, improving post‑meal and fasting blood sugar control.
- Contributes to the reduction of diabetes-related complications when used long term as part of a comprehensive treatment plan (diet, exercise, and regular monitoring).
- Can be combined with other antidiabetic agents to achieve better glycemic control when monotherapy is insufficient.
Warnings & Contraindications:
- Contraindicated in patients with type 1 diabetes mellitus, diabetic ketoacidosis (with or without coma), and in those with known hypersensitivity to glimepiride, other sulfonylureas, sulfonamides, or any component of the formulation.
- Not suitable for the treatment of diabetic ketoacidosis or diabetic pre-coma/coma; insulin therapy is required in these situations.
- Use with caution in patients with impaired liver or kidney function; dose adjustment and close monitoring may be necessary.
- May cause hypoglycemia (low blood sugar), especially in elderly patients, those with irregular meals, intense physical activity, alcohol consumption, or when combined with other glucose-lowering agents.
- Patients should be educated on recognizing and managing signs of hypoglycemia (e.g., sweating, tremor, palpitations, hunger, confusion).
- Alcohol intake may enhance or weaken the blood sugar-lowering effect and should be limited or avoided.
- Use during pregnancy: oral sulfonylureas are generally not recommended. Insulin is preferred. Women planning pregnancy or who become pregnant should consult their doctor immediately.
- Use during breastfeeding: glimepiride may pass into breast milk; breastfeeding is generally not recommended while taking this medicine unless advised otherwise by a doctor.
- May affect the ability to drive or operate machinery if hypoglycemia or hyperglycemia occurs; caution is advised.
- Consult your doctor before use if you are taking other medications (such as other antidiabetics, beta‑blockers, ACE inhibitors, diuretics, corticosteroids, anticoagulants, or NSAIDs) due to potential drug interactions.
- Consult your doctor before use if pregnant, nursing, taking medications, or have medical conditions such as liver disease, kidney disease, adrenal or pituitary insufficiency, or glucose-6-phosphate dehydrogenase (G6PD) deficiency.
- Not intended to diagnose, treat, cure, or prevent any disease without appropriate medical supervision.
- Keep out of reach of children.
Side Effects:
- Common side effects: hypoglycemia (low blood sugar) with symptoms such as sweating, shakiness, headache, hunger, dizziness, palpitations, irritability, or confusion.
- Gastrointestinal effects: nausea, vomiting, abdominal pain, diarrhea, or a feeling of fullness may occur in some patients.
- Allergic reactions: skin rash, itching, redness, urticaria; rarely, severe reactions such as angioedema or anaphylactic reactions may occur.
- Hematologic effects (rare): changes in blood cell counts (e.g., thrombocytopenia, leukopenia, hemolytic anemia), usually reversible after discontinuation.
- Liver-related effects (rare): elevation of liver enzymes, cholestasis, hepatitis; discontinue and seek medical advice if signs of liver dysfunction (e.g., jaundice, dark urine, persistent fatigue) appear.
- Visual disturbances may occur transiently at the start of treatment due to changes in blood glucose levels.
- Seek immediate medical attention if you experience severe or persistent hypoglycemia, difficulty breathing, swelling of the face or throat, severe rash, or any other serious or unusual symptoms.
Storage Instructions:
Store in a cool, dry place away from direct sunlight and moisture. Keep the blister pack or container tightly closed. Do not store above the temperature stated on the package (typically below 25°c, if specified on the pack). Keep out of reach of children. Do not use after the expiry date printed on the packaging.
Specifications:
- Form: tablet.
- Strength: 2 mg glimepiride per tablet.
- Pack size: 30 tablets per pack.
- Route of administration: oral.
- Intended use: prescription antidiabetic medicine for adults with type 2 diabetes mellitus.
Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.



